Cite
Hayashi M, Kawana S, Sekino H, et al. Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase. World J Hepatol. 2018;10(1):166-171doi: 10.4254/wjh.v10.i1.166.
Hayashi, M., Kawana, S., Sekino, H., Abe, K., Matsuoka, N., Kashiwagi, M., Okai, K., Kanno, Y., Takahashi, A., Ito, H., Hashimoto, Y., & Ohira, H. (2018). Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase. World journal of hepatology, 10(1), 166-171. https://doi.org/10.4254/wjh.v10.i1.166
Hayashi, Manabu, et al. "Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase." World journal of hepatology vol. 10,1 (2018): 166-171. doi: https://doi.org/10.4254/wjh.v10.i1.166
Hayashi M, Kawana S, Sekino H, Abe K, Matsuoka N, Kashiwagi M, Okai K, Kanno Y, Takahashi A, Ito H, Hashimoto Y, Ohira H. Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase. World J Hepatol. 2018 Jan 27;10(1):166-171. doi: 10.4254/wjh.v10.i1.166. PMID: 29399290; PMCID: PMC5787680.
Copy
Download .nbib